Relirubicin 50mg Injection
Marketer
Relic Biotechnology Pvt Ltd
Salt Composition
Epirubicin (50mg)
Overview Relirubicin 50mg Injection
Doxorubicin (50mg injectable form) is a cancer treatment effective against various blood, breast, stomach, lung, ovarian, and soft tissue cancers. Post-surgical bladder cancer recurrence prevention is another application. Administered intravenously by a healthcare professional, it's used either alone or in combination chemotherapy regimens. Dosage and frequency are determined by your physician based on your condition and may vary. Adhere strictly to your doctor's instructions; incorrect usage or overdose may lead to severe adverse effects. Therapeutic benefits may take weeks or months to manifest; discontinue only under your doctor's guidance. Reliable contraception is crucial for both men and women during treatment, as it can reduce contraceptive pill effectiveness. Common side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and skin rashes. It can lower blood cell counts, increasing infection risk (potentially life-threatening). Regular blood tests to monitor blood cell counts, kidney, liver, and heart function are vital. Before commencing treatment, disclose any pre-existing liver or heart conditions, and all other medications you are currently taking, as interactions may impact efficacy or function. Inform your doctor if you are pregnant or breastfeeding.
Uses of Relirubicin 50mg Injection
Malignant neoplasm
Major Benefits of Relirubicin 50mg Injection:
Administering this medication requires a healthcare professional (doctor or nurse). Self-medication is not recommended.
Common Side effects of Relirubicin 50mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Relirubicin 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Relirubicin 50mg Injection works:
Docetaxel 50mg Injection is a chemotherapeutic agent targeting breast cancer. Its mechanism involves inhibiting topoisomerase II, a crucial enzyme for DNA replication in cancerous cells. This inhibition, coupled with the generation of cytotoxic free radicals, leads to DNA damage and ultimately halts the proliferation and induces the death of breast cancer cells.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while using Relirubicin 50mg Injection is dangerous.
PregnancyCONSULT YOUR DOCTOR
Administering Relirubicin 50mg Injection to pregnant individuals poses a confirmed risk to the fetus. Therefore, its use during pregnancy is contraindicated except in exceptional life-threatening circumstances where the potential benefits clearly outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Breastfeeding is contraindicated during treatment with Relirubicin 50mg Injection due to the potential for drug-induced infant toxicity.
DrivingUNSAFE
Administering Relirubicin 50mg Injection might induce adverse reactions impacting driving capabilities. Nausea and vomiting, potential side effects of Relirubicin 50mg Injection, may temporarily compromise safe driving.
KidneySAFE IF PRESCRIBED
The use of Relirubicin 50mg Injection in patients with impaired kidney function appears to present a low risk. Preliminary findings indicate dose modification may be unnecessary for this population. However, physician consultation is advised. For individuals exhibiting serum creatinine exceeding 5 mg/dL, reduced dosages should be evaluated.
LiverCAUTION
Patients with liver impairment should receive Relirubicin 50mg Injection cautiously, potentially requiring dose modification. Consult a physician before administration. Relirubicin 50mg Injection is contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Relirubicin 50mg Injection :
NA
Facts to Know About Relirubicin 50mg Injection
| Label | Value |
|---|---|
| Chemical Category | Anthracycline-based drug |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Actions | Cytotoxic alkaloids |
3,018 People bought this recently